Functional Luminal Imaging Probe (FLIP) Topography Use in Patients With Scleroderma and Trouble Swallowing

Not Recruiting

Trial ID: NCT03270722

Purpose

FLIP topography has been FDA cleared to evaluate a variety of esophageal conditions, but has never been evaluated in patients with scleroderma. The investigators hope to evaluate this technology in patients who have scleroderma and various esophageal symptoms, and compare to non-scleroderma patients.

Official Title

Use of FLIP Topography to Evaluate Esophageal Symptoms in Patients With Scleroderma

Stanford Investigator(s)

John Clarke
John Clarke

Clinical Professor, Medicine - Gastroenterology & Hepatology

Nielsen Fernandez-Becker
Nielsen Fernandez-Becker

Clinical Professor, Medicine - Gastroenterology & Hepatology

Lorinda Chung
Lorinda Chung

Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Dermatology

Eligibility


Inclusion Criteria:

   - Must have a clinical indication for upper endoscopy (recruiting patients both with
   scleroderma and without)

Exclusion Criteria:

   - not healthy enough to undergo an upper endoscopy

   - mass, stricture, ring, or web present on upper endoscopy

   - history of esophageal cancer

   - history of esophageal surgery

Intervention(s):

device: FLIP topography

procedure: Upper Endoscopy

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
John O Clarke, MD
650-736-5555